#HAND

In a well-insured cohort of older people with HIV, antiretroviral treatment didn’t offset the risk for dementia.

A study suggests cannabis use is linked to lower odds of neurocognitive problems in this population.

That’s compared with a control group of HIV-negative individuals in a small study.

A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.

Findings suggest that the older class of HIV drugs may contribute to HIV-associated neurocognitive disorders.

A Campbell Foundation grant helps researches answer that question as they explore HIV-associated neurocognitive disorders (HAND).

Among a group of middle-aged men with well-treated HIV, there was also a link between cognitive decline and a gene connected to Alzheimer’s.

This man’s diagnosis could be an indicator of what is to come for an aging HIV population.

Clinicians at Georgetown University have reported the first case of a person living with HIV receiving a diagnosis of Alzheimer’s disease.

The antidepressant Paxil (paroxetine) led to moderate improvements among people with HIV-related neurocognitive dysfunction.